Effects of corticotropin-releasing hormone receptor antagonists on cocaine-induced dopamine overflow in the medial prefrontal cortex and nucleus accumbens of rats

Synapse

Volumn 57, Issue 4, 2005, Pages 202-212

  Gurkovskaya, Olga V ^a   Palamarchouk, Vitaly ^a   Smagin, Gennady ^a   Goeders, Nick E ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cocaine; CRH; Dopamine; Medial prefrontal cortex; Microdialysis; Nucleus accumbens

Indexed keywords

BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; COCAINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG SELF ADMINISTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REINFORCEMENT; STATISTICAL ANALYSIS;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCAINE; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PYRIMIDINES; PYRROLES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 23044483147     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20172     Document Type: Article

References (68)

1. Anderson SM, Bari AA, Pierce RC. 2003. Administration of the D1-like dopamine receptor antagonist SCH-23390 into the medial nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug-seeking behavior in rats. Psychopharmacology (Berl) 168:132-138.
2. Baker DA, Khroyan TV, O'Dell LE, Fuchs RA, Neisewander JL. 1996. Differential effects of intra-accumbens sulpiride on cocaine-induced locomotion and conditioned place preference. J Pharmacol Exp Ther 279:392-401.
3. Bittencourt JC, Vaughan J, Arias C, Rissman RA, Vale WW, Sawchenko PE. 1999. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol 415:285-312.
4. Caine SB, Heinrichs SC, Coffin VL, Koob GF. 1995. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res 692:47-56.
5. Campbell UC, Carroll ME. 2001. Effects of ketoconazole on the acquisition of intravenous cocaine self-administration under different feeding conditions in rats. Psychopharmacology (Berl) 154:311-318.
6. Capriles N, Rodaros D, Sorge RE, Stewart J. 2003. A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 168:66-74.
7. Carboni E, Silvagni A, Rolando MT, Di Chiara G. 2000. Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs. J Neurosci 20:RC102.
8. Chalmers DT, Lovenberg TW, De Souza EB. 1995. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRFl receptor mRNA expression. J Neurosci 15:6340-6350.
9. Ciccocioppo R, Sanna PP, Weiss F. 2001. Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists. Proc Natl Acad Sci USA 98:1976-1981.
10. De Souza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ. 1985. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci 5:3189-3203.
11. Dunn AJ. 2000. Footshock-induced changes in brain catecholamines and indoleamines are not mediated by CRF or ACTH. Neurochem Int 37:61-69.
12. Dunn AJ, Berridge CW. 1987. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol Biochem Behav 27:685-691.
13. Dunn AJ, Berridge CW. 1990. Is corticotropin-releasing factor a mediator of stress responses? Ann N Y Acad Sci 579:183-191.
14. Erb S, Shaham Y, Stewart J. 1998. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci 18:5529-5536.
15. Erb S, Stewart J. 1999. A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci 19:RC35.
16. Goeders NE, Clampitt DM. 2002. Potential role for the hypothalamo-pituitary-adrenal axis in the conditioned reinforcer-induced reinstatement of extinguished cocaine seeking in rats. Psychopharmacology (Berl) 161:222-232.
17. Goeders NE, Guerin GF. 2000. Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats. Neuropsychopharmacology 23:577-586.
18. Goeders NE, Peltier RL, Guerin GF. 1998. Ketoconazole reduces low dose cocaine self-administration in rats. Drug Alcohol Depend 53:67-77.
19. Goeders NE, Smith JE. 1983. Cortical dopaminergic involvement in cocaine reinforcement. Science 221:773-775.
20. Goeders NE, Smith JE. 1986. Reinforcing properties of cocaine in the medical prefrontal cortex: primary action on presynaptic dopaminergic terminals. Pharmacol Biochem Behav 25:191-199.
21. Grimm JW, See RE. 2000. Dissociation of primary and secondary reward-relevant limbic nuclei in an animal model of relapse. Neuropsychopharmacology. 22:473-479.
22. Gurkovskaya O, Goeders NE. 2001. Effects of CP-154,526 on responding during extinction from cocaine self-administration in rats. Eur J Pharmacol 432:53-56.
23. Homberg JR, van den Akker M, Raaso HS, Wardeh G, Binnekade R, Schoffelmeer AN, de Vries TJ. 2002. Enhanced motivation to self-administer cocaine is predicted by self-grooming behaviour and relates to dopamine release in the rat medial prefrontal cortex and amygdala. Eur J Neurosci 15:1542-1550.
24. Kurd YL, Ponten M. 2000. Cocaine self-administration behavior can be reduced or potentiated by the addition of specific dopamine concentrations in the nucleus accumbens and amygdala, using in vivo microdialysis. Behav Brain Res 116:177-186.
25. Kaddis FG, Uretsky NJ, Wallace LJ. 1995. DNQX in the nucleus accumbens inhibits cocaine-induced conditioned place preference. Brain Res 697:76-82.
26. Kalin NH, Sherman JE, Takahashi LK. 1988. Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats. Brain Res 457:130-135.
27. Kalivas PW, Duffy P, Latimer LG. 1987. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther 242:757-763.
28. Lavicky J, Dunn AJ. 1993. Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem 60:602-612.
29. Lu L, Liu D, Ceng X. 2001. Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats. Eur J Pharmacol 415:203-208.
30. Lu L, Liu Z, Huang M, Zhang Z. 2003. Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes. J Neurochem 84:1378-1386.
31. Maj M, Turchan J, Smialowska M, Przewlocka B. 2003. Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala. Neuropeptides 37:105-110.
32. Maldonado R, Robledo P, Chover AJ, Caine SB, Koob GF. 1993. D1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat. Pharmacol Biochem Behav. 45:239-242.
33. Mantsch JR, Goeders NE. 1999. Ketoconazole blocks the stress-induced reinstatement of cocaine-seeking behavior in rats: relationship to the discriminative stimulus effects of cocaine. Psychopharmacology (Berl) 142:399-407.
34. Mantsch JR, Saphier D, Goeders NE. 1998. Corticosterone facilitates the acquisition of cocaine self-administration in rats: opposite effects of the type II glucocorticoid receptor agonist dexamethasone. J Pharmacol Exp Ther. 287:72-80.
35. Matsuzaki I, Takamatsu Y, Moroji T. 1989. The effects of intracerebroventricularly injected corticotropin-releasing factor (CRF) on the central nervous system: behavioural and biochemical studies. Neuropeptides 13:147-155.
36. McFarland K, Kalivas PW. 2001. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21:8655-8663.
37. McGregor A, Baker G, Roberts DC. 1996. Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 53:5-9.
38. McGregor A, Roberts DC. 1993. Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement. Brain Res 624:245-252.
39. McGregor A, Roberts DC. 1995. Effect of medial prefrontal cortex injections of SCH 23390 on intravenous cocaine self-administration under both a fixed and progressive ratio schedule of reinforcement. Behav Brain Res 67:75-80.
40. McKinzie DL, Rodd-Henricks ZA, Dagon CT, Murphy JM, McBride WJ. 1999. Cocaine is self-administered into the shell region of the nucleus accumbens in Wistar rats. Ann N Y Acad Sci 877:788-791.
41. McLaughlin J, See RE. 2003. Selective inactivation of the dorsomedial prefrontal cortex and the basolateral amygdala attenuates conditioned-cued reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology (Berl) 168:57-65.
42. Menzaghi F, Howard RL, Heinrichs SC, Vale W, Rivier J, Koob GF. 1994. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. J Pharmacol Exp Ther 269:564-572.
43. Morin SM, Ling N, Liu XJ, Kahl SD, Gebiert DR. 1999. Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 92:281-291.
44. Olianas MC, Onali P 1989. Stimulation of synaptosomal dopamine synthesis by corticotropin-releasing factor in rat striatum: role of Ca2+-dependent mechanisms. Eur J Pharmacol 166:165-174.
45. Pan JT, Lookingland KJ, Moore KE. 1995. Differential effects of corticotropin-releasing hormone on central dopaminergic and noradrenergic neurons. J Biomed Sci 2:50-56.
46. Park WK, Bari AA, Jey AR, Anderson SM, Spealman RD, Rowlett JK, Pierce RC. 2002. Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens. J Neurosci 22:2916-2925.
47. Paxinos G, Watson C. 1986. The Rat Brain Stereotaxic Coordinates. San Diego: Academic Press.
48. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale W 1994. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 91:8777-8781.
49. Richter RM, Pich EM, Koob GF, Weiss F. 1995. Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci Lett 187:169-172.
50. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. 1987. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223.
51. Robinson TE, Camp DM. 1991. The effects of four days of continuous striatal microdialysis on indices of dopamine and serotonin neurotransmission in rats. J Neurosci Methods 40:211-222.
52. Rodd-Henricks ZA, McKinzie DL, Li TK, Murphy JM, McBride WJ. 2002. Cocaine is self-administered into the shell but not the core of the nucleus accumbens of Wistar rats. J Pharmacol Exp Ther 303:1216-1226.
53. Sanchez CJ, Bailie TM, Wu WR, Li N, Sorg BA. 2003. Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior. Neuroscience 119:497-505.
54. Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G. 1993. Alterations of corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration in rats. Brain Res 616:315-319.
55. Sauvage M, Steckler T. 2001. Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei-potential implication for arousal and attention. Neuroscience 104:643-652.
56. Schenk S, Horger BA, Peltier R, Shelton K. 1991. Supersensitivity to the reinforcing effects of cocaine following 6-hydroxydopamine lesions to the medial prefrontal cortex in rats. Brain Res 543:227-235.
57. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidt AW, Seeger T, Seymour P, Tingley FD, III, Winston EN, Chen YL, Heym J. 1996. CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci USA 93:10477-10482.
58. Shaham Y, Erb S, Leung S, Buczek Y, Stewart J. 1998. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology (Berl) 137:184-189.
59. Smagin GN, Goeders NE. 2000. Ketoconazole enhances cocaine-induced dopamine release in the medial prefrontal cortex (Mpfc) in rats. Neurosci Abstr. 26:1822.
60. Spyraki C, Fibiger HC, Phillips AG. 1982. Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res 253:195-203.
61. Steketee JD. 2003. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res Rev 41:203-228.
62. Swanson LW, Sawchenko PE, Rivier J, Vale WW. 1983. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165-186.
63. Vale W, Spiess J, Rivier C, Rivier J. 1981. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213:1394-1397.
64. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE. 2000. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191-212.
65. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W. 1995. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378:287-292.
66. Yamamoto H, Maeda T, Fujimura M, Fujimiya M. 1998. Urocortin-like immunoreactivity in the substantia nigra, ventral tegmental area and Edinger-Westphal nucleus of rat. Neurosci Lett 243:21-24.
67. Zhou Y, Spangler R, LaForge KS, Maggos CE, Ho A, Kreek MJ. 1996. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"- pattern cocaine administration and chronic withdrawal. J Pharmacol Exp Ther 279:351-358.
68. Zhou Y, Spangler R, Ho A, Kreek MJ. 2003. Increased CRH mRNA levels in the rat amygdala during short-term withdrawal from chronic 'binge' cocaine. Brain Res Mol Brain Res 114:73-79.